At LumaCyte, we are guided by a team of visionary leaders and distinguished experts dedicated to driving innovation and accelerating the delivery of life-saving therapies. This diverse group brings extensive experience, providing strategic guidance and scientific insight to ensure the highest standards of excellence and integrity in all that we do. Their collective expertise and unwavering commitment to advancing cutting-edge technologies are shaping the future of cellular analysis and elevating biomanufacturing to new heights.
Board of Directors & Scientific Advisors
Sean J. Hart, PhD
CEO & Chief Scientific Officer
Board Member
Dr. Hart, co-founder and original inventor of Laser Force Cytology™, led the development of the technology and its transformational applications. A scientific visionary and business leader with extensive experience in analytical science, multivariate data analysis and machine learning/AI for predictive and prescriptive modeling, driving LumaCyte’s advanced analytics to the next level.
Renée A. Hart
President & Chief Business Officer
Board Member
Co-founder and seasoned life sciences executive with 25+ years of experience in business development, marketing, and operations management. Known for deep expertise across the biopharmaceutical, clinical drug development, and life science software sectors, driving innovative solutions and accelerating global growth across these industries.
Paul M. Meister
Board Member
Analytical instrumentation life science industry veteran with 3 decades of experience across large global growth companies. Mr. Meister served as President of MacAndrews & Forbes Incorporated in his last role, with previous executive positions as Chairman and CEO of inVentiv Health (now Syneos Health) and former Chairman of the Board at Thermo Fisher Scientific.
Robert F. Heiser
Board Member
Experienced business executive with a diverse background ranging from commercial real estate to advanced biodiesel manufacturing, bringing a diverse and unique background to bear on business, technology, and global markets.
Peter L. Buzy
Board Member
Experienced life science executive with 25+ years of successful executive management experience. Former President, Gene Therapy Catalent. Prior to joining Catalent, Mr. Buzy served as President & Chief Executive Officer of Paragon, having joined the company in 2014 as its COO.
Dennis Walczewski, MBA
Board Member
Experienced life science executive with 30+ years in biotechnology (Diagnostics, Research Reagents and Manufacturing). Former CEO, MBL International.
Phillip Roux
Board Member
20 years experience in strategy and value creation across life sciences consulting, with deep experience in strategy development and execution, performance management and M&A. Currently VP, Strategy at Spectris Scientific.
Meret Gaugler, PhD
Scientific Advisor
Senior life sciences executive bringing deep scientific and private equity business experience across advanced cellular therapies and tools. Current partner-at-large, Growth Investments, Novo Holdings.
Jim Robinson
Scientific Advisor
Experienced scientific and business executive in the vaccine and biologics sector with previous leadership roles at Merck, Sanofi and Novovax. Jim’s deep expertise in vaccine development and manufacturing awarded him past Vice Chair, CEPI Scientific Advisory Board.
